More than 1,500 people who have sought support from the vaccine damage payment scheme after being injured or bereaved as a ...

A dose of the new Moderna spikevax autumn Covid booster vaccination before it is ... More than 1,500 people who have sought support from the vaccine damage payment scheme after being injured ...

Moderna's new version of its COVID-19 vaccine, which targets two virus variants ... and is being positioned as a second booster shot that could be used in forthcoming immunisation campaigns.

Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...

Shares of vaccine maker Moderna fell Wednesday as Goldman Sachs lowered its rating after the biotech’s second cut to product ...

Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.

High vaccine wastage and low vaccination and booster rates marred the government’s P74.68-million COVID-19 National ...

Goldman Sachs downgraded Moderna (MRNA) to Neutral from Buy with a price target of $51, down from $99. The recent product revenue guidance ...

Kennedy Jr. Wednesday during a Senate Finance hearing about his decision to keep a financial stake in litigation against a major vaccine maker. Ethics records released in advance of the hearing ...

Moderna (NASDAQ:MRNA) traded lower in the premarket on Wednesday after Goldman Sachs downgraded the COVID-19 vaccine maker to Neutral from Buy, citing a lack of clarity over its revenue outlook.

Kennedy, who has advocated against the safety of vaccines for decades, tried to distance himself from his past vaccine denials. By Clarissa-Jan Lim Robert F. Kennedy Jr. downplayed and denied his ...